Perioperative hepatic functional risk assessed with technetium-99m diethylenetriamine pentaacetic acid galactosyl human serum albumin liver scintigraphy in patients undergoing pancreaticoduodenectomy complicated by obstructive jaundice

被引:12
作者
Nakano, H
Kumada, K
Takekuma, Y
Hasebe, S
Yoshizawa, Y
Yamaguchi, M
Jaeck, D
机构
[1] CHU Hautepierre, Serv Chirurg Hepat & Digest, Ctr Chirurg Viscerale & Transplantat, F-67098 Strasbourg, France
[2] Showa Univ, Fujigaoka Hosp, Dept Surg, Aoba Ku, Yokohama, Kanagawa 2278501, Japan
[3] Showa Univ, Fujigaoka Hosp, Dept Gastroenterol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan
[4] Showa Univ, Fujigaoka Hosp, Dept Radiol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan
关键词
technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin liver scintigraphy; obstructive jaundice; pancreatic; biliary; and ampullary carcinomas; pancreaticoduodenectomy; perioperative hepatic functional risk;
D O I
10.1385/IJGC:25:1:3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conclusion: Liver scintigraphy with technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin (Tc-GSA) can be used to predict outcome of biliary drainage and hepatic function after pancreaticoduodenectomy in patients with pancreatic, biliary, and ampullary carcinomas complicated by obstructive jaundice. Background: Preoperative obstructive jaundice has been reported as a crucial risk factor for serious postoperative complications in patients undergoing pancreaticoduodenectomy. The aim of the present study was to investigate whether Tc-GSA liver scintigraphy can assess hepatic functional risk in patients with pancreatic, biliary, and ampullary carcinomas complicated by obstructive jaundice. Methods: Liver scintigraphy was performed before biliary drainage in 18 patients with obstructive jaundice. The maximum removal rate of Tc-GSA (GSA-R-max standard normal value greater than or equal to 0.60) was calculated. These patients underwent pancreaticoduodenectomy with wide lymphadenectomy. The efficacy of preoperative biliary drainage was assessed with the decrease in serum bilirubin concentration in the first week after biliary drainage. Postoperative liver function was assessed with the increase in serum bilirubin concentration, which was the difference between the immediate preoperative and maximal postoperative bilirubin concentrations. Results: Serum bilirubin decreased more in the first week after biliary drainage in patients with GSA-R-max greater than or equal to 0.60 (7.64 +/- 1.09 mg/Dl/wk) than in patients with GSA-R-max < 0.60 (3.56 +/- 1.25 mg/DL/wk, p = 0.042). Postoperative bilirubin increased less in patients with GSA-R-max greater than or equal to 0.60 (0.81 +/- 0.30 mg/dL) than in patients with GSA-R-max < 0.60 (4.00 +/- 0.69 mg/DL, p = 0.0012). Multivariate analysis showed that GSA-R-max significantly predicted the postoperative bilirubin increase (p = 0.020).
引用
收藏
页码:3 / 9
页数:7
相关论文
共 30 条
[1]   HEPATIC RECOGNITION AND CATABOLISM OF SERUM GLYCOPROTEINS [J].
ASHWELL, G ;
STEER, CJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (20) :2358-2364
[2]   IMPROVEMENTS IN SURVIVAL BY AGGRESSIVE RESECTIONS OF HILAR CHOLANGIOCARCINOMA [J].
BAER, HU ;
STAIN, SC ;
DENNISON, AR ;
EGGERS, B ;
BLUMGART, LH .
ANNALS OF SURGERY, 1993, 217 (01) :20-27
[3]  
COSTALOS C, 1984, BIOL NEONATE, V46, P57, DOI 10.1159/000242034
[4]  
GREY JD, 1988, BRIT J SURG, V75, P216
[5]  
HAKAWA SK, 1991, J NUCL MED, V32, P2233
[6]   Prediction of postoperative decompensated liver function by technetium-99m galactosyl human serum albumin liver scintigraphy in patients with hepatocellular carcinoma complicating chronic liver disease [J].
Kim, YK ;
Nakano, H ;
Yamaguchi, M ;
Kumada, K ;
Takeuchi, S ;
Kitamura, N ;
Takahashi, H ;
Hasebe, S ;
Midorikawa, T ;
Sanada, Y .
BRITISH JOURNAL OF SURGERY, 1997, 84 (06) :793-796
[7]  
KOKUDO N, 1995, TRANSPLANTATION, V60, P200
[8]   REDUCED ANTIOXIDATIVE CAPACITY IN LIVER-MITOCHONDRIA FROM BILE-DUCT LIGATED RATS [J].
KRAHENBUHL, S ;
TALOS, C ;
LAUTERBURG, BH ;
REICHEN, J .
HEPATOLOGY, 1995, 22 (02) :607-612
[9]  
KUDO M, 1992, AM J GASTROENTEROL, V87, P865
[10]  
Kwon A, 1997, HEPATOLOGY, V25, P426